In the post-COVID world, VCs say it’s not as easy to get excited about investing in digital health. Deal activity in healthcare IT was relatively flat in Q1 2024 at 74 total deals, valued at about $1 billion total, up only 3% from the year-ago quarter, according to PitchBook data. Still, promising startups have grabbed […]
10 of the most exciting digital health startups of 2024, according to VCs Read More »
A relatively new startup called EvolutionaryScale has secured a massive tranche of cash to build AI models to generate novel proteins for scientific research. EvolutionaryScale today announced that it raised $142 million in a seed round led by ex-GitHub CEO Nat Friedman, Daniel Gross and Lux Capital with participation from Amazon and NVentures, Nvidia’s corporate
EvolutionaryScale, backed by Amazon and Nvidia, raises $142M for protein-generating AI Read More »
The urgency of the Covid-19 pandemic may be in the past, but the need for fast and secure ways to send valuable, fragile medicines and their components around the world is still quite relevant. SkyCell has developed hardware and software to run that transport process better — and greener, it says — than before, and
SkyCell nabs $59M more for its greener smart pharma transport containers Read More »
Ask any of the health-focused VCs to name one of the top AI startups and one name comes up over and over again: a company based in Pittsburgh called Abridge. And it’s a startup that launched before OpenAI was a household name and LLMs entered the common Valley vocabulary. In 2019, Shiv Rao, a practicing
How Abridge became one of the most talked about healthcare AI startups Read More »
Tempus, a genomic testing and data analysis company started by Eric Lefkofsky, who previously founded Groupon, debuted on Nasdaq on Friday, rising about 15% on the opening. The company priced its IPO on Thursday at $37 apiece, at the top of its $35 to $37 price range, raising nearly $411 million at a fully diluted
Venture fundraising has been a slog over the last few years, even for firms with a strong track record. That’s Foresite Capital’s experience. Despite having 47 IPOs, 28 M&As and 58 FDA-approved drugs under its belt, the 13-year-old multi-stage healthcare and life sciences firm took two years to raise its sixth fund. “Almost all of
Anterior, a company that uses AI to expedite health insurance approval for medical procedures, has raised a $20 million Series A round at a $95 million post-money valuation led by NEA, according to two people familiar with the deal. Existing investors Sequoia, which led Anterior’s $3.2 million seed round last September, and Neo, an accelerator
Anterior grabs $20M from NEA to expedite health insurance approvals with AI Read More »
Two years ago, Prolific Machines unveiled its technology for a unique manufacturing approach to grow cells for industries, including cultivated meat. Today, the Emeryville, Calif.-based company said it’s ready to go to market with a bioreactor that will make that growth possible. Deniz Kent, Max Huisman and Declan Jones started the company in 2020 to
Over half of Americans wear corrective glasses or contact lenses. While there isn’t a shortage of low-cost and luxury frames available online or in stores, consumers can only buy them with a current eyeglass prescription. That means that they first need an eye exam from an optometrist to receive that prescription. But, due to a
In 1816, French physician René Laennec invented an instrument that allowed doctors to listen to human hearts and lungs. That device — a stethoscope — eventually evolved from a simple wooden tube to a lightweight two-earpiece version most doctors today wear on their necks. Eko Health, a startup founded in 2013, is bringing this ubiquitous
Eko Health scores $41M to detect heart disease earlier and more accurately Read More »
